Sitemap
September 17, 2024 Articles
Filter by Available Specialty
- AKI may be linked to higher dialysis need, mortality for hospitalized patients
- ANI Pharmaceuticals completes acquisition of Alimera Sciences
- Anti-Ro antibodies in lupus portend higher disease activity, steroid use
- Asthma, metabolic syndrome worsen COVID-19 outcomes
- Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
- CDC: Close contact of Missouri bird flu case had symptoms but was not tested
- Consistent research necessary to understand myopia as a disease
- Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases
- Earlier use of targeted therapies may delay MS disease progression over 5 years
- Economic burden of ovarian cancer can exceed $200,000 per year, based on treatment phase
- FDA approves expanded indication for pacing leads to include conduction pacing of LBB area
- FDA clears implantable CGM with sensor that lasts up to 1 year
- FDA grants orphan drug designation for ATSN-201 for X-linked retinoschisis
- Future of AI could mean streamlined clinical care, better connection with patients
- Head and neck melanoma associated with more adverse prognostic features
- Honoring National Suicide Prevention Month: Latest data, developments
- Insulin resistance measure may be ‘simple and cost-effective’ gout prediction tool
- Lack of prenatal care, testing fueling rise in congenital syphilis-related stillbirths
- Low-dose metformin associated with central centrifugal cicatricial alopecia improvement
- Minimally invasive chevron and Akin osteotomy may be effective for hallux valgus deformity
- Minimally invasive hallux valgus correction may yield bony union at 6 months
- Mouthwash test could detect risk for recurrence of head and neck cancer
- New oral obesity drug safe, linked to weight loss in first-in-human study
- Novel approach may eliminate survival disparity in HSCT, greatly expand access
- Nurse-led cognitive behavioral therapy program reduces insomnia symptoms
- Oral achondroplasia therapy receives FDA breakthrough therapy designation
- Patients with stroke younger, present with more severe symptoms since COVID-19
- Positive topline data reported in phase 3 trial of nerandomilast in adults with IPF
- Premarket research not conducted for many CV devices subject to class I recall
- Q&A: When to use digital breast tomosynthesis for cancer screening
- Q&A: Company seeks to expand neffy FDA approval to more pediatric patients
- Remote monitoring, pharmacy telehealth visits improved BP control among rural patients
- Scurvy hospitalizations have increased among children in US
- Stay up to date: Healio recaps pivotal guidelines for GI, liver disease in 2024 (so far)
- Text message reminders improve inhaler adherence in asthma, COPD
- Top in ID: Salmonella outbreak prompts egg recall; poxvirus IsrRAPXV may be zoonotic
- Transplant society asks CMS to delay launch of new payment model
- VIDEO: Femtosecond laser trabeculotomy shows pressure reduction at 3 years
- VIDEO: How sharing our stories changes the culture in medicine
- ZIP code, social vulnerability affect access to liver transplant in alcohol-related disease